| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ASTHMA |
1 Human Genetics Research Division, University of Southampton, Southampton SO16 6YD, UK
2 Division of Infection, Inflammation and Repair, University of Southampton, Southampton SO16 6YD, UK
3 Genome Therapeutics Corporation, Waltham, MA 02453-8443, USA
4 Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA
5 Department of Clinical and Experimental Medicine, Section of Respiratory Diseases, University of Padua, Italy
Correspondence to:
Correspondence to:
Dr I Sayers, Malaghan Institute of Medical Research, P O Box 7060, Wellington, New Zealand;
Dr_Ian_Sayers{at}hotmail.com
Background: LTC4 synthase is essential for the production of cysteinyl leukotrienes (Cys-LT), critical mediators in asthma. We have identified a novel promoter polymorphism at position -1072 (G/A) and a -444 (A/C) polymorphism has previously been reported. The role of these polymorphisms in the genetic susceptibility to asthma was examined.
Methods: To test for genetic association with asthma phenotypes, 341 white families (two asthmatic siblings) and 184 non-asthmatic control subjects were genotyped. Genetic association was assessed using case control and transmission disequilibrium test (TDT) analyses. LTC4S promoter luciferase constructs and transiently transfected human HeLa and KU812F cells were generated to determine the functional role of these polymorphisms on basal transcription.
Results: No associations were observed in case control analyses (–1072 A, q=0.09; -444 C, q=0.29); the TDT identified a borderline association between the -444 C allele and bronchial responsiveness to methacholine (p=0.065). Asthmatic children with the -444 C allele had a lower mean basal forced expiratory volume in 1 second (97.4 v 92.7% predicted, p=0.005). LTC4S promoter luciferase analyses provided no evidence for a functional role of either polymorphism in determining basal transcription.
Conclusion: This study does not support a role for these polymorphisms in genetic susceptibility to asthma but provides evidence to suggest a role in determining lung function parameters.
Keywords: leukotriene C4 synthase gene (LTC4S); asthma; polymorphism
This article has been cited by other articles:
|
|
 |
|
  M. Back Cysteinyl-Leukotrienes in Cerebrovascular Disease: Angels and Demons? Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 805 - 806. [Full Text] [PDF]
|
|
|
|
|
|
J. J. Freiberg, A. Tybjaerg-Hansen, H. Sillesen, G. B. Jensen, and B. G. Nordestgaard Promotor Polymorphisms in Leukotriene C4 Synthase and Risk of Ischemic Cerebrovascular Disease Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 990 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Konstantinidis, S. J. Barton, I. Sayers, I. A. Yang, J. L. Lordan, S. Rorke, J. B. Clough, S. T. Holgate, and J. W. Holloway Genetic association studies of interleukin-13 receptor {alpha}1 subunit gene polymorphisms in asthma and atopy Eur. Respir. J., July 1, 2007; 30(1): 40 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. P. Hall and I. Sayers Pharmacogenetics and asthma: false hope or new dawn? Eur. Respir. J., June 1, 2007; 29(6): 1239 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kanaoka and J. A. Boyce Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses J. Immunol., August 1, 2004; 173(3): 1503 - 1510. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
